Biomerica, Inc.
(NASDAQ:BMRA)
$1.11
0.05 (4.72%)
Open: 12:45 PM
Biomerica Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
Biomerica Stock Price Today
Biomerica, Inc. (BMRA) stock rallied over 4.72% intraday to trade at $1.11 a share on NASDAQ. The stock opened with a loss of -10.38% at $0.95 and touched an intraday high of $1.05, rising 4.72% against the last close of $1.06. The Biomerica, Inc. in stock market went to a low of $0.91 during the session.
Biomerica Stock Snapshot
$1.06
Prev. Close
18.67 Million
Market Cap
$0.91
Day Low
$0.95
Open
16.82 Million
Number of Shares
$1.05
Day High
N/A
P/E ratio
-0.42
EPS (TTM)
0.47
Cash Flow per Share
N/A
Free Float in %
0.64
Book Value
31006.00
Volume
Biomerica Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
Employees62.00
Beta-0.94
Sales or Revenue$5.42 Million
5Y Sales Change24.03%
Fiscal Year EndsMay. 2023
SectorHealthcare
IndustryMedical Devices
About Company
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Peers
Frequently Asked Questions
What is the current Biomerica, Inc. (BMRA) stock price?
Biomerica, Inc. (NASDAQ: BMRA) stock price is $1.11 in the last trading session. During the trading session, BMRA stock reached the peak price of $1.05 while $0.91 was the lowest point it dropped to. The percentage change in BMRA stock occurred in the recent session was 4.72% while the dollar amount for the price change in BMRA stock was $0.05.
BMRA's industry and sector of operation?
The NASDAQ listed BMRA is part of Medical Devices industry that operates in the broader Healthcare sector. Biomerica, Inc. , a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide.
Who are the executives of BMRA?
Mr. Steven Sloan
Chief Financial Officer & Treasurer
Mr. Allen C. Barbieri
Executive Vice-Chairman & Corporation Sec.
Hans Boehringer
Senior Vice President of POC R&D
Mr. Zackary S. Irani
Chairman & Chief Executive Officer
How BMRA did perform over past 52-week?
BMRA's closing price is 0.17% higher than its 52-week low of $0.7 where as its distance from 52-week high of $4.17 is -0.74%.
How many employees does BMRA have?
Number of BMRA employees currently stands at 62.00. BMRA operates from 17571 Von Karman Avenue, Irvine, CA 92614, US.
Link for BMRA official website?
Official Website of BMRA is: https://www.biomerica.com
How do I contact BMRA?
BMRA could be contacted at phone #949 645 2111 and can also be accessed through its website. BMRA operates from 17571 Von Karman Avenue, Irvine, CA 92614, US.
How many shares of BMRA are traded daily?
BMRA stock volume for the day was 31006.00 shares. The average number of BMRA shares traded daily for last 3 months was 55.22 Thousands.
What is the market cap of BMRA currently?
The market value of BMRA currently stands at $18.67 Million with its latest stock price at $1.11 and 16.82 Million of its shares outstanding.